Back to Events

Describing Populations and the Appropriate Use of Population Descriptors: Considerations and Implications

Sunday, December 1, 2024 at 12:00 AM (CST) to Friday, December 31, 2027 at 11:59 PM (CST)

On-Demand Video

2023 Meeting the Challenge Summit

Population Descriptors in Dermatology 

Session 3: Describing Populations and the Appropriate Use of Population Descriptors: Considerations and Implications

This meeting was planned and organized by the 2023-2024 SOCS Diversity in Dermatology Clinical Trials Task Force co-chaired by Drs. Valerie D. Callender and Valerie M. Harvey. More details can be found here

Lecture: Population Descriptors in Research: What to Use and Why?

Speaker: Junko Takeshita, MD, PhD, FAAD

Assistant Professor, Department of Dermatology, Department of Biostatistics, Epidemiology and Informatics,

Perelman School of Medicine at the University of Pennsylvania

Dr. Takeshita is a board-certified dermatologist and epidemiologist who leads an R01-funded research program that is dedicated to identifying, understanding, and eliminating health and healthcare disparities related to dermatologic diseases, particularly chronic inflammatory skin diseases. She uses quantitative, qualitative and mixed methods research techniques to study health disparities and has authored many scientific publications on the topics of racial and ethnic health and healthcare disparities in psoriasis, atopic dermatitis, and acne; psoriasis comorbidities; and comparative effectiveness research.

Dr. Takeshita is a recipient of an Outstanding New Investigator Award and Distinguished Leader in Health Equity Award from the National Psoriasis Foundation, a Young Investigator Award from the American Academy of Dermatology, and a Young Physician-Scientist Award from the American Society for Clinical Investigation. She receives/has received grant funding from the National Institutes of Health, the Dermatology Foundation, the National Psoriasis Foundation, and the National Eczema Association to support her independent research program.


Lecture: Translating Population Descriptors into Valid and Reliable Tools and Navigating Demographic Aggregation

Speaker: Suephy C. Chen, MD, FAAD

Professor of Dermatology & Chair of the Department of Dermatology, Duke University School of Medicine

Dr. Chen is an internationally recognized health services researcher with focus in cutaneous melanoma and pigmented lesions as well as teledermatology.  She was one of the pioneers to study the quality of life impact of dermatologic conditions, most recently, itch. 

Dr. Chen was named chair of the Department of Dermatology in January, 2021 at Duke University, School of Medicine. Before joining the Duke faculty, Dr. Chen was Vice Chair and Professor of Dermatology at Emory University.


Lecture: Population Descriptors: A Regulatory Perspective

Speaker: Jill Lindstrom, MD, FAAD

Senior Physician, Office of Immunology and Inflammation, FDA

Dr. Lindstrom is a board-certified dermatologist currently serving as Senior Physician, Office of Immunology and Inflammation, at the US Food and Drug Administration. She earned her undergraduate and medical degrees from Northwestern University. After serving eight years in the US Army, during which she completed her residency at the Walter Reed Army Medical Center, she practiced in both private and academic settings, but spent most of her career in regulatory medicine at the FDA. Interests include pharmaceutical development, clinical trial design, and regulatory oversight for dermatology products.


Lecture: Equitable Augmented Intelligence

Speaker: Art Papier, MD, CEO

CEO and Co-Founder, VisualDx

Associate Professor of Dermatology and Medical Informatics, University of Rochester

Dr. Papier is an Associate Professor of Dermatology at the University of Rochester School of Medicine and Dentistry and CEO of VisualDx. As a dermatologist, Dr. Papier has a particular interest in designing clinical systems that leverage the human ability for pattern recognition, thereby increasing clinical accuracy and reducing diagnostic error at the point of care. In line with this goal, he has led the development of VisualDx, the first diagnostic clinical decision support system to be widely used, and to incorporate machine learning for skin rashes and lesions. The focus of his work is to assist medical decisions by professionals and people alike, with decision support and AI augmenting human intelligence.

Moderator

Tarannum Jaleel, MD, FAAD

Assistant Professor of Dermatology, Duke University School of Medicine

Dr. Jaleel is an Assistant Professor of Dermatology and Director of the Hidradenitis Suppurativa (HS) clinic at Duke. Her research is focused on elucidating the role of sex hormones in hidradenitis suppurativa with the aim of identifying novel biomarkers and potentially new therapeutic strategies for this disease.   She is also the director of sponsored clinical trials education at Duke Dermatology and has significant experience in conducting clinical trials.   In addition to her research and clinical care for patients with HS at Duke, she has worked with HS patients in the community to form an active Triangle Hope for HS support group chapter and serves as the co-medical director of the local chapter where she helps organize informative educational sessions several times a year.